NASDAQ:CPIX Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free CPIX Stock Alerts $1.53 +0.11 (+7.75%) (As of 06/11/2024 ET) Add Compare Share Share Today's Range$1.44▼$1.5950-Day Range$1.40▼$1.7852-Week Range$1.38▼$2.36Volume2,118 shsAverage Volume10,901 shsMarket Capitalization$21.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Cumberland Pharmaceuticals alerts: Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for AprilIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.Read More CPIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPIX Stock News HeadlinesJune 3, 2024 | americanbankingnews.comCumberland Pharmaceuticals (NASDAQ:CPIX) Research Coverage Started at StockNews.comMay 29, 2024 | msn.com2 people injured in Cumberland County plane crash identifiedMay 29, 2024 | msn.comSheriff's Office to pull resource, traffic officers from most Cumberland County SchoolsMay 29, 2024 | msn.comBGMU hoping to have portion of Cumberland Trace Road open by the weekendMay 28, 2024 | msn.comCumberland County dispatcher awarded for helping to deliver babyMay 28, 2024 | msn.comCumberland County sheriff denies claims that tactical team was intoxicated during Lewiston shooting responseMay 27, 2024 | msn.comSmall plane crashes in Cumberland County, multiple people injuredMay 27, 2024 | msn.comLake Cumberland marina heavily damaged by stormsMay 27, 2024 | msn.comNew Cumberland residents come together for Memorial DayMay 27, 2024 | yahoo.comPlane engulfed in flames after crash near Gray’s Creek Airport in Cumberland County, witnesses sayMay 27, 2024 | msn.com3 people injured in plane crash in Cumberland CountyMay 27, 2024 | msn.comSolicitor arrested in Cumberland Co. for allegedly assaulting, shouting slurs at driverMay 27, 2024 | msn.comNearly 2K Cumberland Electric customers without power after strong stormsMay 27, 2024 | nj.comSee all homes sold in Cumberland County, May 20 to May 26May 27, 2024 | msn.comSmall plane crashes, becomes engulfed, injuring multiple people in Cumberland County near Fayetteville.May 26, 2024 | yahoo.comPlane crash in Cumberland County reportedly leaves three injured Sunday morningMay 26, 2024 | yahoo.comNearly 10K Cumberland Electric customers without power after strong stormMay 26, 2024 | yahoo.comCumberland University masters program meets milestonesMay 25, 2024 | msn.comPart of I-83 in Cumberland County reopens after multi-vehicle crashMay 25, 2024 | msn.comMan accused of trying to rob Cumberland Farms in Boston at gunpointMay 24, 2024 | msn.comPart of I-83 in Cumberland County closed after multi-vehicle crashMay 24, 2024 | msn.comCumberland House, Sask., in state of emergency due to impassable highwayMay 24, 2024 | nj.com10 most expensive homes sold in Cumberland County, May 13-19May 23, 2024 | msn.comMan arrested after victim texts 'help' to Cumberland County policeMay 23, 2024 | yahoo.comCumberland man jailed on felony assault chargeSee More Headlines Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today6/11/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CPIX CUSIP23077010 CIK1087294 Webwww.cumberlandpharma.com Phone(615) 255-0068Fax615-255-0094Employees91Year Founded1999Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,280,000.00 Net Margins-21.67% Pretax Margin-21.52% Return on Equity0.21% Return on Assets0.08% Debt Debt-to-Equity Ratio0.59 Current Ratio1.37 Quick Ratio1.21 Sales & Book Value Annual Sales$39.55 million Price / Sales0.52 Cash Flow$0.72 per share Price / Cash Flow2.01 Book Value$1.96 per share Price / Book0.73Miscellaneous Outstanding Shares14,190,000Free Float8,046,000Market Cap$20.43 million OptionableOptionable Beta0.23 Social Links 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. A. J. Kazimi MBA (Age 66)Founder, Chairman, President & CEO Comp: $952.53kMr. John Michael Hamm (Age 68)VP & CFO Comp: $258.38kMr. James Lowrance Herman (Age 69)Executive VP of National Accounts & Chief Compliance Officer Comp: $372.27kMr. Chris T. Bitterman (Age 59)Vice President of Sales & Marketing Comp: $290.87kMr. Todd M. Anthony (Age 63)Vice President of Organizational Development Comp: $304.94kMs. Jean W. Marstiller (Age 74)Senior VP of Administrative Services & Corporate Secretary Comp: $282.17kMr. Adam S. Mostafa (Age 44)Managing Director Ms. Erin Smith GullSenior Corporate Relations AssociateMore ExecutivesKey CompetitorsAssembly BiosciencesNASDAQ:ASMBRecro PharmaNASDAQ:REPHEli Lilly and CompanyNYSE:LLYJohnson & JohnsonNYSE:JNJMerck & Co., Inc.NYSE:MRKView All Competitors CPIX Stock Analysis - Frequently Asked Questions How have CPIX shares performed in 2024? Cumberland Pharmaceuticals' stock was trading at $1.7917 on January 1st, 2024. Since then, CPIX stock has decreased by 14.6% and is now trading at $1.53. View the best growth stocks for 2024 here. When is Cumberland Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our CPIX earnings forecast. How were Cumberland Pharmaceuticals' earnings last quarter? Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released its earnings results on Tuesday, May, 7th. The specialty pharmaceutical company reported ($0.06) earnings per share (EPS) for the quarter. The specialty pharmaceutical company had revenue of $8.50 million for the quarter. Cumberland Pharmaceuticals had a negative net margin of 21.67% and a positive trailing twelve-month return on equity of 0.21%. What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO? 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cumberland Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS). Who are Cumberland Pharmaceuticals' major shareholders? Cumberland Pharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas. View institutional ownership trends. How do I buy shares of Cumberland Pharmaceuticals? Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CPIX) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredNVDA to close the AI “wealth window’ June 25?On Tuesday, June 25, in front of executives from nearly every major tech company in existence, key leaders at ...Paradigm Direct | Sponsored"If I Die, I’d Trust 50% of My Daughters’ Inheritance in ONE Stock.""I'd Feel Secure Putting 50% of My Kids' Inheritance in THIS Stock" One Wall Street millionaire bought AAPL...Stansberry Research | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cumberland Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.